Clinical Trial Update: Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis [NA]

View source ↗

Summary

A clinical trial evaluating tauroursodeoxycholic acid for hepatobiliary disease in cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Tauroursodeoxycholic acid (tauroursodeoxycholic acid)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Cystic Fibrosis | NA | Status: COMPLETED